Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/12/2026 | Q4 | $74.6T | -- | -- | $0.14 | -- |
| 11/12/2025 | Q3 | $67B | $68.8B | $0.27 | $0.15 | $0.13 |
| 08/14/2025 | Q2 | $59.5B | $58.1B | $0.20 | $0.10 | $0.10 |
| 05/16/2025 | Q1 | $53.9B | $50B | $0.18 | -- | -- |
| 03/14/2025 | Q4 | $63.2B | $65.9B | $0.20 | -- | -- |
| 11/14/2024 | Q3 | $56.9B | $57.4B | $0.22 | -- | -- |
| 08/14/2024 | Q2 | $46.7B | $47.9B | $0.15 | -- | -- |
| 05/15/2024 | Q1 | $42.4B | $42.1B | $0.10 | -- | -- |
| 03/14/2024 | Q4 | $58.1B | $58.1B | $0.24 | -- | -- |
| 11/14/2023 | Q3 | $48.3B | $48.7B | $0.19 | -- | -- |
| 08/14/2023 | Q2 | $42.4B | $42.5B | $0.15 | -- | -- |
| 05/11/2023 | Q1 | -- | $48.1B | $0.06 | -- | -- |
| 03/15/2023 | Q4 | -- | $62.6B | $0.18 | -- | -- |
| 11/10/2022 | Q3 | -- | $57.4B | $0.18 | -- | -- |
| 08/10/2022 | Q2 | -- | $51.3B | $0.16 | -- | -- |
| 05/12/2022 | Q1 | -- | $50.2B | $0.15 | -- | -- |
| 03/16/2022 | Q4 | -- | $67.9B | $0.23 | -- | -- |
| 11/12/2021 | Q3 | -- | $50.5B | $0.19 | -- | -- |
| 08/12/2021 | Q2 | -- | $48.3B | $0.15 | -- | -- |
| 05/14/2021 | Q1 | -- | $48B | $0.14 | -- | -- |
| 03/30/2021 | Q4 | -- | $70.6B | $0.23 | -- | -- |
| 11/12/2020 | Q3 | -- | $44B | $0.15 | -- | -- |
| 08/12/2020 | Q2 | -- | $37.8B | $0.11 | -- | -- |
| 05/15/2020 | Q1 | -- | $30.9B | $0.01 | -- | -- |
| 12/31/2019 | Q4 | -- | $57.1B | $0.22 | -- | -- |
| 09/30/2019 | Q3 | -- | $44.5B | $0.14 | -- | -- |
| 06/30/2019 | Q2 | -- | $37.3B | $0.08 | -- | -- |
| 03/31/2019 | Q1 | -- | $34.2B | $0.09 | -- | -- |
| 12/31/2018 | Q4 | -- | $58.7B | $0.29 | -- | -- |
| 09/30/2018 | Q3 | -- | $44.9B | $0.12 | -- | -- |
| 06/30/2018 | Q2 | -- | $36.3B | $0.08 | -- | -- |
| 03/31/2018 | Q1 | -- | $35.1B | $0.12 | -- | -- |
| 12/31/2017 | Q4 | -- | $57.5B | $0.34 | -- | -- |
| 09/30/2017 | Q3 | -- | $35.6B | $0.10 | -- | -- |
| 06/30/2017 | Q2 | -- | $30.5B | $0.08 | -- | -- |
| 03/31/2017 | Q1 | -- | $31.4B | $0.13 | -- | -- |
| 12/31/2016 | Q4 | -- | $44.2B | $0.31 | -- | -- |
| 09/30/2016 | Q3 | -- | $34B | $0.16 | -- | -- |
| 06/30/2016 | Q2 | -- | $28.5B | $0.08 | -- | -- |
| 03/31/2016 | Q1 | -- | $28.9B | $0.12 | -- | -- |
| 12/31/2015 | Q4 | -- | $43.8B | $0.23 | -- | -- |
Hon Hai Precision Industry Co., Ltd. reported $68.8B worth of top line sales in its most recent quarter.
Hon Hai Precision Industry Co., Ltd. announced earnings per share of $0.27 which represents a beat of analyst forecast a $0.15 per share.
Hon Hai Precision Industry Co., Ltd. reported $4.4B that represents $0.62 per share over the last quarter.
Hon Hai Precision Industry Co., Ltd.'s earnings are forecast to decrease from $0.67 per share to $0.48 per share next year representing a decrease of -28.74%.
Hon Hai Precision Industry Co., Ltd.'s next earnings date is March 12, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.